Merck Tbk. vs Multi Medika Internasional Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Multi Medika Internasional Tbk. trades at Rp760 (market cap 3.72T, 43.61M 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 2.2× Merck Tbk.'s market cap, and Multi Medika Internasional Tbk. is more actively traded (43.61M versus 37.6K). Which is the better fit depends on your goals.
| MERK | MMIX | |
|---|---|---|
Market Cap | 1.7T | 3.72T |
Volume | 37.6K | 43.61M |
Lot | 376 | 436.07K |
Turnover | 144.47M | 34.14B |
Average Price | 3,842.23 | 783.01 |
Value | 144.47M | 34.14B |
Indicative Equilibrium Price | 3,840 | 760 |
Indicative Equilibrium Volume | 7 | 3.21K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →